The trademark application RHOLISTIX was filed by Kadmon Pharmaceuticals, LLC, a Limited Liability Company (the "Applicant"). The application was published for oppositions on November 3, 2020, and it was registered by office on February 10, 2021 without any oppositions.
The application was filed in English (German was selected as the second language).